Investors shrug off what appears to be old news about an FDA recall of Vascular Solutions (VASC +5.3%) Guardian II valve, pushing the stock higher after Piper Jaffray initiated the shares with an Overweight rating and an $18 price target. The company had issued its own recall of the valve earlier this month, citing a slightly increased risk of air leakage that may lead to an air embolism, which could result in serious injury or death.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs